The benefit-to-risk trade-offs associated with PSA screening are highly sensitive to patient preference, underscoring the importance of ensuring that men have the opportunity to decide for themselves whether they wish to have their individual risk for suffering and death from prostate cancer assessed through PSA screening.
|Original language||English (US)|
|Journal||ONCOLOGY (United States)|
|State||Published - Feb 15 2014|
ASJC Scopus subject areas